XML 65 R34.htm IDEA: XBRL DOCUMENT v3.26.1
Income Taxes (Tables)
12 Months Ended
Dec. 31, 2025
Income Tax Disclosure [Abstract]  
Schedule of significant components of the company's deferred tax asset
   
December 31,
   
December 31,
 
   
2025
   
2024
   
USD thousands
   
USD thousands
 
Net operating loss carryforward
   
44,464
     
*40,755
 
Capital losses
   
3,271
     
-
 
Share-based compensation expense
   
374
     
351
 
Capitalized research and development costs
   
1,742
     
3,103
 
Other
   
8
     
10
 
Deferred tax assets
   
49,859
     
44,219
 
Less - valuation allowance
   
(49,859
)
   
(44,219
)
                 
Net deferred tax assets, net of valuantion allowance
   
-
     
-
 
Schedule of roll forward of valuation allowance
   
USD thousands
 
Balance at December 31, 2022
 
$
41,195
 
Currency translation Income
   
(3,295
)
Increase in valuation allowance
   
5,571
 
Balance at December 31, 2023
 
$
43,471
 
Currency translation Income
   
(2,459
)
Increase in valuation allowance
   
3,207
 
Balance at December 31, 2024
   
44,219
 
Increase in valuation allowance for capital losses
   
3,271
 
Increase in valuation allowance
   
2,916
 
Decrease in valuation allowance
   
(547
)
Net increase during the year
   
5,640
 
Balance at December 31, 2025
   
49,859
 
Schedule of reconciliation of theoretical income tax expense to actual income tax expense
   
2025 Amount
   
%
 
Israeli statutory income tax rate
   
(2,069
)
   
23.0
%
Nontaxable income or nondeductible expenses:
               
Share-based compensation
   
120
     
(1.3
)%
Other
   
5
     
(0.1
)%
Change in valuation allowance
   
2,297
     
(25.5
)%
Other
   
(344
)
   
3.8
%
                 
Foreign tax effects
   
(9
)
   
0.1
%
                 
Actual income tax expenses
   
-
     
0.0
%
 
   
December 31,
   
December 31,
 
   
2024
   
2023
 
   
USD thousands
   
USD thousands
 
             
Loss before income taxes
   
(13,945
)
   
(24,221
)
Statutory tax rate
   
23
%
   
23
%
Theoretical tax benefit
   
(3,207
)
   
(5,571
)
                 
Change in temporary differences for which deferred taxes were not recognized
   
858
     
(1,177
)
Tax rate differential
   
9
     
10
 
Non-deductible expenses
   
148
     
346
 
Losses and other items for which a valuation allowance was provided or benefit from loss carryforwards
   
2,192
     
6,392
 
Actual income tax expense (Benefit)
   
-
     
-
 
Schedule of income (loss) before income taxes by jurisdiction
   
2025
   
2024
   
2023
 
   
USD thousands
   
USD thousands
   
USD thousands
 
Israel
   
(9,035
)
   
(13,925
)
   
(23,534
)
Foreign
   
40
     
(20
)
   
(687
)
                         
Total
   
(8,995
)    
(13,945
)
   
(24,221
)